Defining the Outcome Markers and Therapeutic Role for Omalizumab in Treatment of Allergic Bronchopulmonary Aspergillosis

Paul A. Greenberger*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)906-907
Number of pages2
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume11
Issue number3
DOIs
StatePublished - Mar 2023

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this